Viewing Study NCT05311618


Ignite Creation Date: 2025-12-25 @ 4:52 AM
Ignite Modification Date: 2025-12-26 @ 3:53 AM
Study NCT ID: NCT05311618
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-04-01
First Post: 2022-03-18
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors
Sponsor: NGM Biopharmaceuticals, Inc
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module